J. Duerinck

发表

Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma

B. Neyns, M. Ridder, J. Mey, 2017, Clinical Pharmacokinetics.

Comparison of the effect of anterior and posterior neurosurgical treatment for cervical spondylotic myelopathy: a clinical outcome

M. Moens, J. Duerinck, B. Bourgonjon, 2019, Acta Neurologica Belgica.

Disc Fragment Herniectomy Through a Facet Joint Quadrantectomy for Extraforaminal Lumbar Herniation: Technique and Results.

P. Mariën, M. Moens, R. Brouns, 2016, World neurosurgery.

Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach

Hester F. Lingsma, J. Bartek, P. Hutchinson, 2020, Acta Neurochirurgica.

The effect of augmented reality on the accuracy and learning curve of external ventricular drain placement.

J. Vandemeulebroucke, A. Gallagher, S. Elprama, 2021, Neurosurgical focus.

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

B. Neyns, A. Michotte, O. Tynninen, 2011, Journal of Neuro-Oncology.

Procedures performed during neurosurgery residency in Europe

C. Bolger, W. Vandertop, K. Schaller, 2020, Acta Neurochirurgica.

Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion

B. Neyns, J. Aerts, K. Thielemans, 2016, Cancer Immunology, Immunotherapy.

Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.

B. Neyns, A. Michotte, M. de Ridder, 2012, European journal of cancer.

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

B. Neyns, A. Michotte, P. Theuns, 2020, Journal for ImmunoTherapy of Cancer.

Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.

B. Neyns, A. Michotte, P. Hau, 2015, Anticancer research.

GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide

D. Lambrechts, R. Sciot, G. Bergers, 2022, Frontiers in Oncology.

Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients

B. Neyns, A. Michotte, R. Kefford, 2014, Case reports in oncological medicine.

Randomized phase II study of axitinib versus standard of care in patients with recurrent glioblastoma.

B. Neyns, V. Verschaeve, H. Everaert, 2014 .

Randomized Trial Comparing Burr Hole Craniostomy, Minicraniotomy, and Twist Drill Craniostomy for Treatment of Chronic Subdural Hematoma

C. Raftopoulos, O. De Witte, F. Van Calenbergh, 2022, Neurosurgery.

Regional and experiential differences in surgeon preference for the treatment of cervical facet injuries: a case study survey with the AO Spine Cervical Classification Validation Group

R. Lindtner, J. Chapman, A. Ramieri, 2020, European Spine Journal.

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Y. Saeys, D. Lambrechts, O. De Wever, 2021, Nature Neuroscience.

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies

B. Neyns, K. Movahedi, J. V. Van Ginderachter, 2020, eLife.

Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1

B. Neyns, L. Van De Voorde, J. Duerinck, 2020, Case Reports in Oncology.

Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab.

B. Neyns, A. Michotte, Shasha Lv, 2012, International Journal of Oncology.

Mini-craniotomy as the primary surgical intervention for the treatment of chronic subdural hematoma—a retrospective analysis

K. V. Van Rompaey, R. Buyl, J. Duerinck, 2014, Acta Neurochirurgica.

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab

B. Neyns, A. Michotte, A. Van Binst, 2018, Cancer medicine.

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

I. Salmon, S. Van Dooren, B. Neyns, 2021, Journal for ImmunoTherapy of Cancer.

Pituitary carcinoma - case series and review of the literature

B. Neyns, B. Velkeniers, C. Andreescu, 2022, Frontiers in Endocrinology.

Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma

B. Neyns, B. Filleul, V. Verschaeve, 2015, Journal of Neurology.

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

I. Salmon, B. Neyns, A. Michotte, 2017, Journal of Neuro-Oncology.

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

I. Salmon, B. Neyns, A. Michotte, 2016, Journal of Neuro-Oncology.

An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals

O. De Witte, I. Salmon, B. Neyns, 2012, Journal of oncology.

Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center

D. Unuane, B. Velkeniers, K. Poppe, 2013, Acta Neurologica Belgica.

Development of dural plasmacytoma after evacuation of chronic subdural hematoma: Case report

A. Michotte, M. Moens, K. Smet, 2012, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

Comparison of the effect of anterior and posterior neurosurgical treatment for cervical spondylotic myelopathy: a clinical outcome

M. Moens, J. Duerinck, B. Bourgonjon, 2019, Acta Neurologica Belgica.

Safety of axitinib plus avelumab in patients with recurrent glioblastoma.

B. Neyns, J. Duerinck, G. Awada, 2018 .

CSF and Blood Neurofilament Levels in Athletes Participating in Physical Contact Sports

S. Engelborghs, M. Bjerke, J. Versijpt, 2021, Neurology.

Augmenting Microsoft's HoloLens with vuforia tracking for neuronavigation

Bart Jansen, Jef Vandemeulebroucke, Taylor Frantz, 2018, Healthcare technology letters.

Retrograde C0-C1 insertion of cervical plate electrode for chronic intractable neck and arm pain.

J. D'haese, B. Nuttin, M. Moens, 2011, World neurosurgery.

Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives

B. Neyns, K. Movahedi, S. Tuyaerts, 2023, Frontiers in Immunology.

Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series

B. Neyns, D. L. Van den Berge, L. Seynaeve, 2023, Cancers.

An international validation of the AO spine subaxial injury classification system

Ng Bing Wui, R. Rasschaert, A. Ramieri, 2022, European spine journal.

Expression of thyroid transcription factor 1 in a chordoid glioma

A. Michotte, J. Duerinck, J. D'haens, 2014, Journal of the Neurological Sciences.

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

A. Michotte, V. Verschaeve, M. Mercier, 2017, Journal of Neuro-Oncology.

Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center

D. Unuane, B. Velkeniers, K. Poppe, 2012, Acta Neurologica Belgica.

J. Duerinck, J. Schwarze, A. Rogiers, 2024, Journal of neuro-oncology.